Susan Brannon
Montgomery, ALNPI 1063548642
Payments from drug & device makers
Across 88 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$455
- Supernus Pharmaceuticals, Inc.$263
- GSK$140
- Ironshore Pharmaceuticals Inc.$114
- Pfizer$92
- Adlon Therapeutics L.p.$84
- plus $321 from 12 others
What the payments were for
- Food & beverage$1,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 25 | $455 |
| Supernus Pharmaceuticals, Inc. | 29 | $263 |
| GSK | 3 | $140 |
| Ironshore Pharmaceuticals Inc. | 5 | $114 |
| Pfizer | 6 | $92 |
| Adlon Therapeutics L.p. | 4 | $84 |
| Tris Pharma Inc | 3 | $52 |
| AstraZeneca | 1 | $38 |
| Sobi, Inc | 2 | $35 |
| Biomarin Pharmaceutical Inc. | 1 | $34 |
| Genentech USA, Inc. | 2 | $30 |
| Seqirus USA Inc | 1 | $29 |
| Biofire Diagnostics, LLC | 1 | $22 |
| Merck | 1 | $20 |
| Neos Therapeutics, LP | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.